查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
帕金森病药物市场规模、份额和趋势分析报告：按药物类别（卡比多巴/左旋多巴、抗胆碱能药）、分销渠道（医院、零售药房）、地区、细分市场预测2022-2030
市场调查报告书
商品编码
1171113

帕金森病药物市场规模、份额和趋势分析报告：按药物类别（卡比多巴/左旋多巴、抗胆碱能药）、分销渠道（医院、零售药房）、地区、细分市场预测2022-2030

Parkinson's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Carbidopa-levodopa, Anticholinergics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

帕金森病药物市场的增长和趋势

Grand View Research, Inc. 的最新报告预测，到 2030 年，全球帕金森病治疗药物市场规模将达到 119.8 亿美元，2022 年至 2030 年的复合年增长率为 12.1%。 这可能是由于增加了对 PD 新疗法研发的投资。 2021 年 8 月，帕金森基金会宣布投资 4300 万美元用于 29 个研究项目的研究资助，旨在开发 PD 的新疗法和疗法。 此外，2021 年 5 月，帕金森基金会宣布投资 1000 万美元用于帕金森病 (PD) 的研究、护理和教育项目。 这项投资将有助于提高认识并为患有 PD 的人提供免费基因检测。

预计此类投资计划将推动该行业的发展。 在过去的十年中，PD 治疗领域出现了重大的研发活动，导致了创新药物输送方法的发展。 由于副作用较少，这些最先进的药物输送系统优于现有系统。 此外，患者依从性的提高导致这些技术的处方率更高，从而推动了行业扩张。 此外，主要製药公司正在开展合作和伙伴关係，以开发、製造和商业化产品，以满足国际市场对疾病治疗日益增长的需求。

例如，2021 年 11 月，STADA Arzneimittel 和 Bioglan 建立了合作伙伴关係，以扩大用于治疗 PD 患者的药物 Lecigon（左旋多巴/卡比多巴/恩他卡朋）的产能。 因此，对用于治疗 PD 患者的药物的需求增加预计将推动行业增长。 但由于神经外科医生数量有限，存在患者等待时间长、医院难以招募新神经外科医生等问题。 而一些目前在实践中的神经科医生避免接受新的医疗补助患者，这使得想要切换到另一位医生的患者变得困难。 美国神经病学学会 (AAN) 的一份报告预测，到 2025 年，将出现约 19% 的神经科医生短缺。

帕金森病治疗药物市场报告要点

按药物类别划分，卡比多巴和左旋多巴部分在 2021 年占销售额的最大份额，因为 PD 患病率高且治疗该疾病的药物随时可用 *2021 年，零售药店分销渠道部分在全球占据主导地位行业。

这是因为 PD 药物在成熟的零售连锁药店（包括沃尔格林和沃尔玛）随时可用

由于新产品进入市场，预计亚太地区在预测期内增长最快

2020 年 6 月，Ono Pharmaceutical Co., Ltd. 在日本获得了用于治疗 PD 患者的 Ogencys 的生产和销售批准

内容

第1章调查方法及范围

  • 市场细分和范围
    • 细分范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析
      • 方法：产品流方法
  • 调查假设
  • 二级信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场展望

第 3 章帕金森病药物市场变量、趋势和范围

  • 母公司市场展望
    • 中枢神经系统药物市场
  • 描绘渗透率和增长前景
  • 监管和报销方案
  • 市场驱动因素分析
    • 帕金森病的患病率增加
    • 拥有强大的渠道
    • 新型给药系统的介绍
  • 市场製约因素分析
    • 治疗费用高
    • 神经科医生和神经外科医生短缺
  • 主要交易和战略联盟
  • 管道分析
  • SWOT 因素分析（政治和法律、经济、技术）
  • 行业分析 - 搬运工

第 4 章帕金森药物市场：竞争分析

  • 主要市场进入者的近期趋势和影响分析
    • 新产品发布
    • 併购
    • 伙伴关係和战略协作
    • 会议和活动
  • 公司分类
    • 创新者
    • 市场领导者
    • 热图分析
  • 供应商情况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
  • 2021 年主要参与者的市场份额分析
  • 上市公司
    • 企业市场分析
    • 竞争仪表板分析
      • 市场差异化因素
  • 私人公司
    • 主要初创公司名单
    • 本地网络地图

第 5 章帕金森病药物市场：细分分析，按药物类别，2018-2030 年（百万美元）

  • 帕金森病治疗市场：药物类别的变化分析
  • 卡比多巴-左旋多巴
  • 多巴胺激动剂
  • MAO-B 抑製剂
  • COMT抑製剂
  • 抗胆碱药
  • 其他

第 6 章。帕金森病药物市场：细分分析，按分销渠道，2018-2030 年（百万美元）

  • 帕金森病治疗市场：分销渠道波动分析
  • 医院药房
  • 零售药房
  • 在线药店

第 7 章帕金森病药物市场：按地区划分的细分分析，2018-2030 年（百万美元）

  • 定义和范围
  • 2021 年和 2030 年区域市场份额分析
  • 区域市场概况
  • 2021-2030 年市场规模、预测、收入和趋势分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多边环境协定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第 8 章帕金森药物市场：公司概况

  • 公司简介
    • Cerevel Therapeutics
      • 公司简介
      • 财务业绩
      • 产品基准
      • 最近的发展
    • 诺华公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 最近的发展
    • 梯瓦製药工业有限公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 最近的发展
    • 默克公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 最近的发展
    • 葛兰素史克公司 (GSK)
      • 公司简介
      • 财务业绩
      • 产品基准
      • 最近的发展
    • 艾伯维公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 最近的发展
    • H. Lundbeck A/S
      • 公司简介
      • 财务业绩
      • 产品基准
    • Amneal Pharmaceuticals LLC。
      • 公司简介
      • 财务基准
      • 产品基准
      • 最近的发展
    • Supernus Pharmaceuticals, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 最近的发展
Product Code: GVR-4-68039-990-7

Parkinson's Disease Treatment Market Growth & Trends:

The global Parkinson's disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from 2022 to 2030. This can be attributed to the rising investment in the research and development of novel treatments for PD. In August 2021, the Parkinson's Foundation announced an investment of USD 43 million as a research grant to 29 research projects having the goal of developing novel treatments and therapies for PD. In addition, in May 2021, the Parkinson's Foundation announced an investment of USD 10 million for research, care, and educational programs related to Parkinson's Disease (PD). This investment may aid in providing awareness and genetic testing free of cost to people suffering from PD.

Such investment initiatives are expected to boost industry growth. In the last ten years, there have been significant R&D activities in the PD therapy sector, leading to the development of innovative drug-delivery methods. Due to fewer side effects, these cutting-edge drug delivery systems outperform the existing ones. In addition, the rate of prescription for these techniques has increased due to a rise in patient compliance, which is fueling the expansion of the industry. Moreover, key pharmaceutical companies are undertaking initiatives, such as collaborations and partnerships, for the development, manufacturing & commercialization of products to meet the rising demand for disease treatment in the international market.

For instance, in November 2021, STADA Arzneimittel and Bioglan formed a partnership to expand the production capacity of the medicine Lecigon (levodopa/carbidopa/entacapone) used to treat patients with PD. Thus, increasing demand for medicines that are used to treat patients with PD is anticipated to drive industry growth. However, the limited availability of neurologists leads to issues, such as longer waiting times for patients and difficulty in hiring new neurosurgeons in hospitals. In addition, some of the currently practicing neurologists avoid accepting new Medicaid patients, which creates difficulty for patients who want to switch to another doctor. According to the American Academy of Neurology (AAN) report, around 19% shortage of neurologists is projected by 2025.

Parkinson's Disease Treatment Market Report Highlights:

  • By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment* The retail pharmacy distribution channel segment dominated the global industry in 2021
  • This is due to the easy availability of PD drugs in well-established retail pharmacy chains including Walgreens and Walmart
  • Asia Pacific is expected to be the fastest-growing region during the forecast period due to the entry of new products into the market
  • In June 2020, Ono Pharmaceutical Co., Ltd. received manufacturing and marketing approval for Ongentys to treat patients with PD in Japan

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Parkinson's Disease Treatment Market Variables, Trends, and Scope

  • 3.1 Parent Market Outlook
    • 3.1.1 Central Nervous System Therapeutics Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory & Reimbursement Scenario
  • 3.4 Market Driver Analysis
    • 3.4.1 Increasing prevalence of Parkinson's disease
    • 3.4.2 Presence of strong pipeline drugs
    • 3.4.3 Introduction of novel drug delivery systems
  • 3.5 Market Restraint Analysis
    • 3.5.1 High treatment cost
    • 3.5.2 Lack of neurologist and neurosurgeons
  • 3.6 Major Deals and Strategic Alliances
  • 3.7 Pipeline Analysis
  • 3.8 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.9 Industry Analysis - Porter's

Chapter 4 Parkinson's Disease Treatment Market: Competitive Analysis

  • 4.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 4.1.1 New Product Launches
    • 4.1.2 Mergers and Acquisitions
    • 4.1.3 Partnerships and Strategic Collaboration
    • 4.1.4 Conferences and Campaigns
  • 4.2 Company Categorization
    • 4.2.1 Innovators
    • 4.2.2 Market Leaders
    • 4.2.3 Heat map analysis
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
  • 4.4 Key Company Market Share Analysis, 2021
  • 4.5 Public Companies
    • 4.5.1 Company market position analysis
    • 4.5.2 Competitive dashboard analysis
      • 4.5.2.1 Market Differentiators
  • 4.6 Private Companies
    • 4.6.1 List of key emerging companies
    • 4.6.2 Regional Network Map

Chapter 5 Parkinson's Disease Treatment Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

  • 5.1 Parkinson's Disease Treatment Market: Drug Class Movement Analysis
  • 5.2 Carbidopa-Levodopa
    • 5.2.1 Carbidopa-levodopa market, 2018 - 2030 (USD Million)
  • 5.3 Dopamine Agonists
    • 5.3.1 Dopamine agonists market, 2018 - 2030 (USD Million)
  • 5.4 MAO-B Inhibitors
    • 5.4.1 MAO-B inhibitors market, 2018 - 2030 (USD Million)
  • 5.5 COMT inhibitors
    • 5.5.1 COMT inhibitors market, 2018 - 2030 (USD Million)
  • 5.6 Anticholinergics
    • 5.6.1 Anticholinergics market, 2018 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Others market, 2018 - 2030 (USD Million)

Chapter 6 Parkinson's Disease Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Parkinson's Disease Treatment Market: Distribution Channel Movement Analysis
  • 6.2 Hospital Pharmacy
    • 6.2.1 Hospital pharmacy market, 2018 - 2030 (USD Million)
  • 6.3 Retail Pharmacy
    • 6.3.1 Retail pharmacy market, 2018 - 2030 (USD Million)
  • 6.4 Online Pharmacy
    • 6.4.1 Online pharmacy market, 2018 - 2030 (USD Million)

Chapter 7 Parkinson's Disease Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2021 & 2030
  • 7.3 Regional Market Snapshot
  • 7.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
    • 7.4.1 North America
      • 7.4.1.1 North America Parkinson's disease treatment, 2018-2030 (USD Million)
      • 7.4.1.2 U.S.
      • 7.4.1.2.1 U.S. Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.1.3 Canada
      • 7.4.1.3.1 Canada Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.2 Europe
      • 7.4.2.1 Europe Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.2 U.K.
      • 7.4.2.2.1 U.K. Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.3 Germany
      • 7.4.2.3.1 Germany Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.4 Spain
      • 7.4.2.4.1 Spain Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.5 France
      • 7.4.2.5.1 France Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.6 Italy
      • 7.4.2.6.1 Italy Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.3 Asia Pacific
      • 7.4.3.1 Asia Pacific Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.2 Japan
      • 7.4.3.2.1 Japan Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.3 China
      • 7.4.3.3.1 China Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.4 India
      • 7.4.3.4.1 India Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.5 South Korea
      • 7.4.3.5.1 South Korea Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.6 Australia
      • 7.4.3.6.1 Australia Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.4 Latin America
      • 7.4.4.1 Latin America Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.4.2 Brazil
      • 7.4.4.2.1 Brazil Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.4.3 Mexico
      • 7.4.4.3.1 Mexico Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.4.4 Argentina
      • 7.4.4.4.1 Argentina Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.5 MEA
      • 7.4.5.1 MEA Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.5.2 South Africa
      • 7.4.5.2.1 South Africa Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.5.3 Saudi Arabia
      • 7.4.5.3.1 Saudi Arabia Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.5.4 UAE
      • 7.4.5.4.1 UAE Parkinson's disease treatment market, 2018 - 2030 (USD Million)

Chapter 8 Parkinson's Disease Treatment Market: Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 Cerevel Therapeutics
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 recent Developments
    • 8.1.2 Novartis AG
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Recent Developments
    • 8.1.3 Teva Pharmaceutical Industries Ltd
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Recent Developments
    • 8.1.4 Merck & Co., Inc.
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Recent Developments
    • 8.1.5 GlaxoSmithKline plc. (GSK)
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Recent Developments
    • 8.1.6 AbbVie, Inc.
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product Benchmarking
      • 8.1.6.5 Recent Developments
    • 8.1.7 H. Lundbeck A/S
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
    • 8.1.8 Amneal Pharmaceuticals LLC.
      • 8.1.8.1 Company Overview
      • 8.1.8.3 Financial Benchmarking
      • 8.1.8.4 Product Benchmarking
      • 8.1.8.5 Recent Developments
    • 8.1.9 Supernus Pharmaceuticals, Inc.
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Parkinson's Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Global Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 U.S. Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 Canada Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 Canada Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Europe Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Europe Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Germany Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Germany Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 U.K. Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 19 U.K. Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 France Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 France Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 Italy Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 23 Italy Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 Spain Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 Spain Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 Asia Pacific Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Japan Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Japan Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 China Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 32 China Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 India Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 34 India Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 South Korea Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 36 South Korea Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Australia Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 38 Australia Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Latin America Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 40 Latin America Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Latin America Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Brazil Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Brazil Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Mexico Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Mexico Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Argentina Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 47 Argentina Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Middle East & Africa Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Middle East & Africa Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Middle East & Africa Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Saudi Arabia Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 52 Saudi Arabia Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 South Africa Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 South Africa Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 UAE Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 56 UAE Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Parkinson's Disease Treatment Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation

Fig. 9 Market Outlook (2021)

  • Fig. 10 Penetration and Growth Prospect Mapping
  • Fig. 11 Parkinson's Disease Treatment Market Driver Impact
  • Fig. 12 Parkinson's Disease Treatment Market Restraint Impact
  • Fig. 13 Major Deals and Strategic Alliances
  • Fig. 14 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 15 Porter's Five Forces Analysis
  • Fig. 16 Heat Map Analysis
  • Fig. 17 Company Market Share Analysis (2021)
  • Fig. 18 Company Market Position Analysis (2021), Revenue Analysis
  • Fig. 19 Company Market Position Analysis (2021), Profit Margin Analysis
  • Fig. 20 Market Differentiators
  • Fig. 21 Regional Network Map
  • Fig. 22 Parkinson's Disease Treatment Market Drug Class Outlook: Key Takeaways
  • Fig. 23 Parkinson's Disease Treatment Market: Drug Class Movement Analysis
  • Fig. 24 Carbidopa-Levodopa Market, 2018 - 2030 (USD Million)
  • Fig. 25 Dopamine Agonist Market, 2018 - 2030 (USD Million)
  • Fig. 26 MAO-B Inhibitors Market, 2018 - 2030 (USD Million)
  • Fig. 27 COMT Inhibitors Market, 2018 - 2030 (USD Million)
  • Fig. 28 Anticholinergics Market, 2018 - 2030 (USD Million)
  • Fig. 29 Others Market, 2018 - 2030 (USD Million)
  • Fig. 30 Parkinson's Disease Treatment Market Distribution Channel Outlook: Key Takeaways
  • Fig. 31 Parkinson's Disease Treatment Market: Distribution Channel Movement Analysis
  • Fig. 32 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 33 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 34 Online Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 35 Regional Outlook, 2020 & 2030
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 North America
  • Fig. 38 North America Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S.
  • Fig. 40 U.S. Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada
  • Fig. 42 Canada Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe
  • Fig. 44 Europe Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 45 U.K.
  • Fig. 46 U.K. Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany
  • Fig. 48 Germany Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain
  • Fig. 50 Spain Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 51 France
  • Fig. 52 France Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy
  • Fig. 54 Italy Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific
  • Fig. 56 Asia Pacific Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan
  • Fig. 58 Japan Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 59 China
  • Fig. 60 China Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 61 India
  • Fig. 62 India Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea
  • Fig. 64 South Korea Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia
  • Fig. 66 Australia Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America
  • Fig. 68 Latin America Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil
  • Fig. 70 Brazil Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 71 Mexico
  • Fig. 72 Mexico Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina
  • Fig. 74 Argentina Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 75 Middle East and Africa
  • Fig. 76 MEA Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa
  • Fig. 78 South Africa Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia
  • Fig. 80 Saudi Arabia Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE
  • Fig. 82 UAE Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)